Company Overview
Company Type: Public Company
Website: www.thermofisher.com
Number of Employees: 130,000
Ticker: TMO (NYSE)
Year Founded: 1956


Business Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Financial Information (Currency: CAD, in mm) 
Total Revenue
59,531.3
Market Capitalization
266,472.7
TEV/Total Revenue
5.2x
EBITDA
14,542.2
Total Enterprise Value
308,946.4
TEV/EBITDA
20.6x
EBIT
9,891.8
Cash & ST Invst.
4,285.3
P/Diluted EPS Before Extra
34.0x
Net Income
7,825.1
Total Debt
46,536.0
Price/Tang BV
NM
Capital Expenditure
(2,515.3)
Total Assets
128,714.9
Total Debt/EBITDA
3.1x
Currency in CAD in mm, LTM as of Jul-01-2023 TEV and Market Cap are calculated using a close price as of Oct-05-2023


Estimates & Guidance Snapshot (Current Fiscal Year End: Dec-31-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Guidance Current FQ
Current FY
Guidance Current FY
NTM
EPS Normalized
7.76
-
30.66
30.47 - 31.08
32.37
Revenue (mm)
14,689.08
-
59,887.31
59,361.65 - 60,182.32
61,307.62
EBITDA (mm)
3,860.09
-
15,287.44
-
15,908.92

Forward Multiples (Current FY)

Price/Earnings
22.22x
TEV/REV
5.16x
TEV/EBITDA
20.21x
PEG
1.84x
P/BV
4.14x

Non-Periodic Estimates

Recommendation
Outperform (1.81)
Target Price
848.77
Potential Upside
24.60%
LT Growth (%)
12.07%
Guidance - LT Growth (%)
20.00%


Key Professionals
Name
Title
Casper, Marc N.
Chairman, President & CEO
Williamson, Stephen 
Senior VP & CFO
Lagarde, Michel 
Executive VP & COO
Holmes, Joseph R.
VP & Chief Accounting Officer
Nelson, Karen E.
Chief Scientific Officer & Member of Scientific Advisory Board
Snyder, Ryan J.
Senior VP & Chief Information Officer
Tejada, Rafael 
Vice President of Investor Relations
Boxer, Michael A.
Senior VP & General Counsel
Pound, Sandy B.
VP & Chief Communications Officer
Parker, Paul G.
Senior Vice President of Strategy & Corporate Development
Britt, Lisa P.
Chief Human Resources Officer & Senior VP
Bauer, Konrad 
Senior Vice President of Global Business Services

Key Board Members
Name
Title
Casper, Marc N.
Chairman, President & CEO
Nelson, Karen E.
Chief Scientific Officer & Member of Scientific Advisory Board
Chai, Nelson Juseuk
Independent Director
Sorensen, Lars Rebien
Independent Director
Spar, Debora L.
Independent Director
Weisler, Dion J.
Independent Director
Sperling, Scott M.
Independent Lead Director
Chandy, Ruby R.
Independent Director
Conrads, Thomas 
Member of Scientific Advisory Board
Gygi, Steven P.
Member of Scientific Advisory Board
Hahn, William C.
Member of Scientific Advisory Board
Harris, C. Martin
Independent Director & Member of Scientific Advisory Board


Primary Industry Classification
Life Sciences Tools and Services


Primary Office Location
168 Third Avenue | Waltham, MA | 02451 | United States
Phone: 781 622 1000   

Current and Pending Investors
Asset Management Company, Cercano Management, Elo Mutual Pension Insurance Company, Ilmarinen Mutual Pension Insurance Company, Initiate Studios, LLC, Keskinäinen työeläkevakuutusyhtiö Varma, Maxwell (Mauritius) Pte Ltd, T. Rowe Price Associates, Inc., Westech Investment Advisors, LLC

Prior Investors
Child Health Investment Corporation, COI Partners Deutschland GmbH, Massachusetts Capital Resource Company, Temasek Holdings (Private) Limited, VR Adviser, LLC

Investment Arms
Bonsai Venture Capital SA SCR, Thermo Electron Corporation Choice Plan

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 682.80
Market Cap (mm)
266,472.7
Open
 678.17
Shares Out. (mm)
391.2
Previous Close
 681.18
Float %
99.8%
Change on Day
1.61
Shares Sold Short (mm)
2.8
Change % on Day
0.2%
Dividend Yield %
0.3%
Day High/Low
 684.59/ 674.41
Diluted EPS Excl. Extra Items
20.02
52 wk High/Low
 834.14/ 650.75
P/Diluted EPS Before Extra
33.78x
Volume (mm)
0.32
Avg 3M Dly Vlm (mm)
1.46
Beta 5Y
0.79


 
Delayed Quote** | Last Updated on Oct-06-2023 12:06 PM (GMT-5)
NYSE:TMO - Common Stock


Index Membership
S&P Global 100 Index;S&P 500;S&P 500 Health Care (Sector);S&P 100;S&P Composite 1500;S&P 500 Growth;S&P Global 1200;S&P 500 - Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P 500 Equal Weighted;S&P 500 - Life Sciences Tools & Services (Industry);S&P 900 Pure Growth;S&P 900 Growth;S&P 500 - Life Sciences Tools & Services (Sub Ind);S&P TMI Index;S&P Global 1200 Health Care Index;S&P 900;S&P 500 Pure Growth;S&P Composite 1500 - Life Sciences Tools & Services (Industry);S&P Composite 1500 - Life Sciences Tools & Services (Sub Ind);S&P Composite 1500 - Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Composite 1500 Health Care (Sector);S&P Composite 1500 Growth;S&P Composite 1500 Pure Growth;S&P 500 EQUAL WEIGHTED Health Care (Sector);S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index;S&P 500 Dividend Index;S&P Americas BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas BMI Growth Index;S&P Americas BMI Value Index;S&P Americas BMI Index;S&P Americas BMI Health Care (Sector) Index;S&P Americas LargeMidCap Health Care (Sector) Index;S&P Developed BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas LargeMidCap Index;S&P Americas LargeMidCap Growth Index;S&P Americas LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas LargeMidCap Value Index;S&P Americas Over USD5 Billion Index;S&P Developed Ex-Asia-Pacific LargeMidCap Value Index;S&P Developed BMI Value Index;S&P Developed Ex-Asia-Pacific BMI Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Europe BMI Growth Index;S&P Developed Ex-Europe BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe LargeMidCap Index;S&P Developed Ex-Europe LargeMidCap Growth Index;S&P DM Ex-Europe LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed BMI Index;S&P Developed Ex-Asia-Pacific BMI Growth Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Index;S&P Developed Ex-Australia BMI Index;S&P Developed Ex-Australia LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Growth Index;S&P Developed BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Index;S&P DM Ex-Asia-Pacific BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Asia-Pacific BMI Value Index;S&P Developed Ex-Australia LargeMidCap Index;S&P Developed Ex-Europe BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Canada BMI Index;S&P Developed Ex-Canada BMI Health Care (Sector) Index;S&P Developed Ex-Canada BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Canada LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Index;S&P Developed Ex-Switzerland LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-U.K. LargeMidCap Health Care (Sector) Index;S&P DM Ex-U.K. LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Index;S&P Developed Ex-Eurozone LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed Ex-Eurozone LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Japan BMI Index;S&P Developed Ex-Japan BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Index;S&P Developed Ex-Asia-Pacific LargeMidCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed Ex-Australia BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Australia LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Value Index;S&P Developed Ex-Japan LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Health Care (Sector) Index;S&P Developed Ex-Switzerland LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Growth Index;S&P Developed Ex-Australia BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Health Care (Sector) Index;S&P Developed Ex-Canada BMI Growth Health Care (Sector) Index;S&P DM Ex-Canada LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Japan BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland LargeMidCap Index;S&P Developed Ex-Switzerland LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Health Care (Sector) Index;S&P Developed Ex-Europe LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Europe LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Value Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Value Index;S&P Developed Ex-Eurozone Over USD5 Billion Index;S&P Developed Ex-Switzerland LargeMidCap Growth Index;S&P Developed Ex-Switzerland LargeMidCap Value Index;S&P Developed Ex-Canada BMI Growth Index;S&P Developed Ex-Canada BMI Value Health Care (Sector) Index;S&P Developed Ex-Europe BMI Index;S&P Developed Ex-U.K. BMI Value Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Index;S&P Developed Ex-U.K. Over USD5 Billion Index;S&P Developed Ex-U.K. BMI Growth Index;S&P Developed Ex-U.K. BMI Value Index;S&P Developed Ex-U.K. LargeMidCap Growth Index;S&P Developed Ex-U.K. LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Value Index;S&P Developed BMI Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Over USD5 Billion Index;S&P Developed Ex-Australia BMI Value Health Care (Sector) Index;S&P Developed Ex-Europe Over USD5 Billion Index;S&P Developed Ex-Eurozone BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Value Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Index;S&P Developed Ex-Australia Over USD5 Billion Index;S&P Developed Ex-Canada LargeMidCap Index;S&P Developed Ex-Canada LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Canada Over USD5 Billion Index;S&P Developed Over USD5 Billion Index;S&P Global BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Pan Asia BMI Health Care (Sector) Index;S&P Global Ex-Pan Asia BMI Value Index;S&P Developed Ex-Europe BMI Value Index;S&P Developed Ex-Eurozone BMI Value Index;S&P Developed Ex-Eurozone LargeMidCap Index;S&P Developed Ex-Japan LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Value Index;S&P Developed Ex-Switzerland BMI Growth Index;S&P Developed Ex-Switzerland BMI Growth Health Care (Sector) Index;S&P DM Ex-Switzerland BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland BMI Value Index;S&P Developed Ex-Switzerland LargeMidCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed LargeMidCap Index;S&P Developed LargeMidCap Growth Index;S&P Developed LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland Over USD5 Billion Index;S&P Developed BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Value Index;S&P Developed Ex-Canada BMI Value Index;S&P Developed Ex-Europe BMI Health Care (Sector) Index;S&P Developed Ex-Europe BMI Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Index;S&P Developed Ex-Japan LargeMidCap Growth Index;S&P DM Ex-Japan LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Japan Over USD5 Billion Index;S&P Global Ex-Japan Over USD5 Billion Index;S&P Global Ex-Pan Asia BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Pan Asia LargeMidCap Growth Index;S&P Developed Ex-U.K. BMI Index;S&P Global Ex-Japan BMI Value Index;S&P Global BMI Index;S&P Global Ex-Japan BMI Health Care (Sector) Index;S&P Global Ex-Japan LargeMidCap Index;S&P Global Ex-Japan LargeMidCap Value Index;S&P Global Ex-Pan Asia LargeMidCap Value Index;S&P Global Ex-Pan Asia Over USD5 Billion Index;S&P North America BMI Value Health Care (Sector) Index;S&P North America LargeMidCap Growth Index;S&P North America LargeMidCap Value Health Care (Sector) Index;S&P North America Over USD5 Billion Index;S&P Global Ex-Pan Asia LargeMidCap Health Care (Sector) Index;S&P Global Over USD5 Billion Index;S&P North America BMI Index;S&P North America LargeMidCap Index;S&P North America LargeMidCap Growth Health Care (Sector) Index;S&P North America LargeMidCap Value Index;S&P Global Ex-Japan LargeMidCap Health Care (Sector) Index;S&P Global Ex-Japan LargeMidCap Pharmaceuticals, Biotech & Life Sciences (Industry Group) Index;S&P United States BMI Index;S&P Global LargeMidCap Health Care (Sector) Index;S&P United States BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P North America BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P North America BMI Value Index;S&P Global BMI Growth Index;S&P United States BMI Growth Health Care (Sector) Index;S&P United States BMI Health Care (Sector) Index;S&P United States LargeMidCap Value Health Care (Sector) Index;S&P United States BMI Value Health Care (Sector) Index;S&P United States LargeMidCap Growth Index;S&P United States LargeMidCap Growth Health Care (Sector) Index;S&P United States LargeMidCap Health Care (Sector) Index;S&P United States Over USD5 Billion Index;S&P Global Ex-Japan BMI Growth Index;S&P Global Ex-Japan BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Japan LargeMidCap Growth Index;S&P Global Ex-Pan Asia BMI Index;S&P Global Ex-Pan Asia BMI Growth Index;S&P Global Ex-Pan Asia LargeMidCap Index;S&P Global Ex-Pan Asia LargeMidCap Pharmaceuticals, Biotech & Life Sciences (Industry Group) Index;S&P Global LargeMidCap Index;S&P United States BMI Growth Index;S&P Global LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global LargeMidCap Value Index;S&P North America BMI Growth Index;S&P North America BMI Growth Health Care (Sector) Index;S&P North America BMI Health Care (Sector) Index;S&P North America LargeMidCap Health Care (Sector) Index;S&P North America LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P United States BMI Value Index;S&P Developed BMI Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Growth Index;S&P Developed Ex-Australia LargeMidCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed Ex-Canada LargeMidCap Growth Index;S&P Developed Ex-Canada LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Canada LargeMidCap Value Index;S&P Developed Ex-Europe LargeMidCap Value Index;S&P Developed Ex-Japan BMI Growth Index;S&P Developed Ex-Japan BMI Value Index;S&P Developed Ex-Japan LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Value Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Value Health Care (Sector) Index;S&P Developed LargeMidCap Growth Health Care (Sector) Index;S&P Developed LargeMidCap Health Care (Sector) Index;S&P Developed LargeMidCap Value Index;S&P Developed LargeMidCap Value Health Care (Sector) Index;S&P Global BMI Health Care (Sector) Index;S&P Global BMI Value Index;S&P Global Ex-Japan BMI Index;S&P Global LargeMidCap Growth Index;S&P United States LargeMidCap Index;S&P United States LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P United States LargeMidCap Value Index;S&P 100 Equal Weight Price Return (USD) Index;S&P Developed Ex-Japan BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P United States BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P North America BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Canada BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Growth Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland BMI Growth Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-UK BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Australia BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Value Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Australia BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Switzerland BMI Value Pharm, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-UK BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Europe BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Canada BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P United States BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P North America BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Japan BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P TMI Health Care;S&P Developed Ex-Israel BMI Growth Index;S&P Developed Ex-Israel BMI Growth Health Care (Sector) Index;S&P Developed Ex-Israel BMI Index;S&P Developed Ex-Israel BMI Health Care (Sector) Index;S&P Developed Ex-Israel BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Israel BMI Value Index;S&P Developed Ex-Israel BMI Value Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Growth Index;S&P Developed Ex-Israel LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Index;S&P Developed Ex-Israel LargeMidCap Health Care (Sector) Index;S&P DM Ex-Israel LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Israel LargeMidCap Value Index;S&P Developed Ex-Israel LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Israel Over USD5 Billion Index;S&P Global 1200 - Life Sciences Tools & Services (Industry);S&P Global 1200 - Life Sciences Tools & Services (Sub Ind);S&P Global 1200 - Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Global Ex-Australia BMI Index;S&P Global Ex-Europe BMI Index;S&P Global Ex-United Kingdom BMI Index;S&P Developed Ex-Continental Europe BMI Index;S&P Developed Ex-Japan, Ex-South Korea BMI Index;S&P DM Ex.Japan LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex. Japan LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Global Ex-Australia LargeMidCap;S&P Developed Ex-Japan & South Korea LargeMidCap;S&P 100 Health Care;S&P DM Ex-Canada LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subsecto;S&P DM Ex-Israel LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group;S&P Developed Ex-Switzerland LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Subs;S&P DM Ex-U.K. LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Subsec;S&P Developed Ex-Asia-Pacific LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subs;S&P Developed Ex-Australia LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subsect;S&P DM Ex-Canada LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group;S&P Developed Ex-Israel BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subse;S&P DM Ex-Europe LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group;S&P DM Ex-Europe LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Subsect;S&P Developed LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia-Pacific LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Sub;S&P United States LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-U.K. LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Israel LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America LargeMidCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P United States LargeMidCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Global Ex-Australia & New Zealand LargeMidCap;S&P Global Ex-China A BMI;S&P Global Ex-China A LargeMidCap;S&P Developed Ex-Korea BMI;S&P Global Ex-Japan & China A LargeMidCap;S&P Developed Ex-Korea LargeMidCap;S&P Developed BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific BMI Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland BMI Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia BMI Grwth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland LargeMidCap Grwth Pharma, Biotech & Life Sciences (Industry Group);S&P Developed Ex-Canada LargeMidCap Growth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe LargeMidCap Growth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK LargeMidCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P North America BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK LargeMidCap Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan LargeMidCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific LargeMidCap Grwth Pharma, Biotech & Life Sciences (Industry Group);S&P United States BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific BMI Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia LargeMidCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel LargeMidCap Growth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan LargeMidCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland BMI Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P United States BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Global 100 Capped Index;S&P Developed Ex-Korea BMI Growth;S&P Developed Ex-Korea BMI Value;S&P Developed Ex-Korea LargeMidCap Growth;S&P Developed Ex-Korea LargeMidCap Value;S&P Global 1200 Ex-Canada;S&P Developed Ex-Korea LargeMidCap Health Care (Sector) Index;"S&P Developed Ex-Korea LargeMidCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
CorEvitas, LLC
CorEvitas, LLC develops real-world data and analytics solutions, enabling biopharmaceutical companies to demonstrate the value and differentiation of their products to clinicians, patients, payers, and regulators. CorEvitas, LLC was formerly known as Corrona, LLC and changed its name to CorEvitas, LLC in March 2021. The company was founded in 2000 and is based in Waltham, Massachusetts. As of August 14, 2023, CorEvitas, LLC operates as a subsidiary of Thermo Fisher Scientific Inc.

United States and Canada
Health Care Technology
26.00
-
-
MarqMetrix, Inc.
MarqMetrix, Inc. develops optical sensors and measuring instruments. The company’s products include MarqMetrix optical sensing TouchRaman immersion BallProbes, such as Fiber BallProbes, which is a fiber-coupled Raman immersion probe with a spherical sapphire lens that is mated to the fiber probe with either a gold seal or specially formulated epoxy; Process Elite BallProbes offered in Hastelloy C-276 for applications that require exposure to harsh chemical and extreme physical environments; Performance BallProbes; Standard BallProbes; and Custom BallProbes; as well as the FlowCell BallProbes. Further, the company offers services, including measurement system development and modeling, spectroscopic research and development, analysis, development, and optimization of continuous process reactor systems, sample characterization, multivariate data analysis and data mining, machine learning model development and optimization, and industry consulting. MarqMetrix, Inc. caters to the aviation, aerospace, pharmaceutical, and oil and gas industries. The company was founded in 2012 and is based in Seattle, Washington. As of June 21, 2023, MarqMetrix, Inc operates as a subsidiary of Thermo Fisher Scientific Inc.

United States and Canada
Electronic Equipment and Instruments
4.00
-
-
The Binding Site Group Ltd.
The Binding Site Group Ltd. engages in the research, development, manufacture, and marketing of immunodiagnostic assays and instrumentation to clinicians and laboratory professionals. The company provides Freelite assay those aids in the detection and monitoring of multiple myeloma and related diseases; Hevylite test for heavy and light chain isotype analysis; analyser and software that include Optilite, SPAplus, digital RID plate, TBS data manage; assay menus such as Optilite assay menu, Spa plus assay menu, RID reader assay menu,; immune assay menu that include central nervous systems disorder, complement, immunoglobins, renal function, redial immunodiffusion, specific proteins, vaccine response and sub classes. It also provides Optilite, a protein analysis system; SPAPLUS, an automated system for testing specialist proteins; MININEPHPLUS, a semi-automated nephelometer for low volume specialist protein assays; and a range of CE marked assays for use in analyzers. The company also offers DataSite, a data management software for protein testing. The company markets its solutions through a network of distributors in the United Kingdom and internationally. The company was incorporated in 2005 and is based in Birmingham, United Kingdom with an additional office in San Diego, California. As of January 3, 2023, The Binding Site Group Ltd. operates as a subsidiary of Thermo Fisher Scientific Inc..

Europe
Life Sciences Tools and Services
148.00
-
-
MAX Analytical Technologies, Inc.
MAX Analytical Technologies, Inc. develops FTIR gas analysis technology for in-processes monitoring, source testing, and ambient air monitoring. It offers MAX-iR, MAX-ATS, EMS-10, MAX-Bev, MAX-iAQ, and ASC-10-ST. The company was founded in 2017 and is based in East Windsor, Connecticut. As of March 7, 2022, MAX Analytical Technologies, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.

United States and Canada
Commodity Chemicals
-
-
-
PeproTech, Inc.
PeproTech, Inc. develops, manufactures, and sells recombinant proteins for scientists and researchers in the United States and internationally. The company offers cytokines and antibodies, animal-free cytokines, growth factors and cytokines, chemokines, neurotrophins, proteases, other proteins, cell culture media kits/supplements, and enzyme-linked immunosorbent assay kits; good manufacturing practices cytokines for cell, gene, and tissue therapy; and media supplement kits and media supplement components. It sells its products online. The company was incorporated in 1988 and is based in Cranbury, New Jersey. As of December 30, 2021, PeproTech, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.

United States and Canada
Life Sciences Tools and Services
11.00
-
-
Cell sorting technology assets of Propel Labs, Inc.
As of February 17, 2021, Cell sorting technology assets of Propel Labs, Inc. was acquired by Thermo Fisher Scientific Inc. Cell sorting technology assets of Propel Labs, Inc. comprises a discovery tool for the separation of specific cell types from complex samples. The asset is located in the United States.

United States and Canada
Life Sciences Tools and Services
-
-
-
Mesa Biotech, Inc.
As of February 25, 2021, Mesa Biotech, Inc. was acquired by Thermo Fisher Scientific Inc. Mesa Biotech, Inc. designs, develops, manufactures, and commercializes molecular diagnostic tests. It offers a PCR-based rapid point-of-care testing platform for detecting infectious diseases, including SARS-CoV-2, Influenza A and B, respiratory syncytial virus, and Strep A. Mesa Biotech, Inc. was founded in 2009 and is based in San Diego, California with a satellite testing laboratory in Santa Fe, New Mexico.

United States and Canada
Health Care Equipment
24.00
-
-

Investments as an LP
FinHealth Gestão de Recursos LTDA, Fundo BBI Financial I Fundo Mútuo de Investimento em Empresas Emergentes Inovadoras


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Aug-7-2023
Aug-7-2023
Public Offering
Target
Thermo Fisher Scientific Inc. (NYSE:TMO)


750.00
Aug-7-2023
Aug-7-2023
Public Offering
Target
Thermo Fisher Scientific Inc. (NYSE:TMO)


600.00
Aug-7-2023
Aug-7-2023
Public Offering
Target
Thermo Fisher Scientific Inc. (NYSE:TMO)


600.00
Aug-7-2023
Aug-7-2023
Public Offering
Target
Thermo Fisher Scientific Inc. (NYSE:TMO)


1,000.00
Jul-06-2023
Aug-14-2023
Merger/Acquisition
Buyer
CorEvitas, LLC
Thermo Fisher Scientific Inc. (NYSE:TMO)
Audax Management Company, LLC
912.50
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Oct-05-2023
Business Expansions
Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments
Oct-02-2023
Company Conference Presentations
Thermo Fisher Scientific Inc. Presents at 2023 PDA Pharmaceutical Microbiology Conference, Oct-02-2023 03:25 PM
Sep-27-2023
Company Conference Presentations
Thermo Fisher Scientific Inc. Presents at 2nd mRNA Process Development & Manufacturing Summit, Sep-27-2023 09:00 AM
Sep-26-2023
Company Conference Presentations
Thermo Fisher Scientific Inc. Presents at Generis American Medical Device (AMD) Summit, Sep-26-2023
Sep-26-2023
Company Conference Presentations
Thermo Fisher Scientific Inc. Presents at Outsourcing In Clinical Trials Southern California 2023, Sep-26-2023

Competitors
10x Genomics, Inc. (NasdaqGS:TXG), 1CellBio, Inc, 23andMe Holding Co. (NasdaqGS:ME), 3M Company (NYSE:MMM), 908 Devices Inc. (NasdaqGM:MASS), AB Sciex LLC, ABB Bomem Inc., Abbott Diagnostics GmbH, Abbott Diagnostics Inc., Abbott Laboratories (NYSE:ABT), Abbott Molecular Inc., Abbott Rapid Diagnostics PTY LTD., Abcam plc (NasdaqGS:ABCM), Abdos Polymers Ltd., Accelerate Diagnostics, Inc. (NasdaqCM:AXDX), Accumax Limited, ACEA Biosciences, Inc, Advanced Cell Diagnostics, Inc., Advanced Measurement Technology, Inc., Aes Chemunex, Affymetrix Inc., Agilent Technologies, Inc. (NYSE:A), Ajinomoto Althea, Inc., Akoya Biosciences, Inc. (NasdaqGS:AKYA), Akzo Nobel N.V. (ENXTAM:AKZA), Aldevron, LLC, Alere Inc., Alexion Pharmaceuticals, Inc., Alltech International Holdings, Inc. (Acquired), Alpha Teknova, Inc. (NasdaqGM:TKNO), Ambry Genetics Corporation, AMETEK, Inc. (NYSE:AME), Ancestry.com LLC, ANGLE plc (AIM:AGL), Anton Paar GmbH, Applied Biosystems Ltd., ArcherDx, Inc., AREVA NP SAS, Arkema Inc., ARKRAY, Inc., Aspira Women's Health Inc. (NasdaqCM:AWH), Avacta Group Plc (AIM:AVCT), Avantor, Inc. (NYSE:AVTR), Avid Bioservices, Inc. (NasdaqCM:CDMO), Axygen, Inc., Azenta, Inc. (NasdaqGS:AZTA), BASF Corporation, Bayer Aktiengesellschaft (XTRA:BAYN), Bd Biosciences, Beckman Coulter, Inc., Berthold Technologies Gmbh & Co. Kg, BGI Genomics Co., Ltd. (SZSE:300676), Bio-Rad Laboratories, Inc. (NYSE:BIO), Bio-Techne Corporation (NasdaqGS:TECH), Biocept, Inc. (NasdaqCM:BIOC), Biocon Limited (NSEI:BIOCON), BioControl Medical (B.C.M) Ltd., BioControl Systems, Inc., Biodesix, Inc. (NasdaqGM:BDSX), BioFluidica, Inc., BioLegend, Inc., bioMérieux S.A. (ENXTPA:BIM), bioMérieux, Inc., Bionano Genomics, Inc. (NasdaqCM:BNGO), BioReference Health, LLC, Biosearch Technologies, Inc., BioSource International Inc. (Acquired), Biotest Aktiengesellschaft (XTRA:BIO3), Biotrace International plc (Out of Business), Blacktrace Holdings Limited, Broadcom Inc. (NasdaqGS:AVGO), Bruker AXS, Inc., Bruker Corporation (NasdaqGS:BRKR), Bruker Optics, Inc., Büchi Labortechnik AG, Bureau Veritas SA (ENXTPA:BVI), CAEN S.p.A., Cambrex Corporation, Camfil Farr, Inc., Canon Electronics Inc. (TSE:7739), Canon Inc. (TSE:7751), CareDx, Inc (NasdaqGM:CDNA), Carl Zeiss, Inc., Catalent, Inc. (NYSE:CTLT), Cayman Chemical Company, Inc., Celgene Corporation, Cell Signaling Technology, Inc., Cellular Research, Inc., CELSIS INTERNATIONAL LIMITED, Cepheid, Inc., Charles River Laboratories International, Inc. (NYSE:CRL), Co-Diagnostics, Inc. (NasdaqCM:CODX), Color Health, Inc., Congenica Ltd., Cook Pharmica LLC, Copan Diagnostics, Inc., Corning Incorporated (NYSE:GLW), Corning Life Sciences Inc, Corona Diagnostics, LLC, Cue Health Inc. (NasdaqGS:HLTH), CureVac N.V. (NasdaqGM:CVAC), Curia Global, Inc., Cytek Biosciences, Inc. (NasdaqGS:CTKB), Cytiva, Danaher Corporation (NYSE:DHR), Dassault Systèmes SE (ENXTPA:DSY), DGI Resolution, Inc., DiaSorin Inc., Dionex Corp., DNA Script SAS, Donaldson Company, Inc. (NYSE:DCI), Dover Corporation (NYSE:DOV), Dr. Reddy's Laboratories Limited (BSE:500124), Dupont Nutrition Biosciences ApS, DuPont Qualicon, Inc., Dynapar Corporation, Eclipse Scientific Group Limited (Out of Business), EDAX Inc., Element Biosciences, Inc., Eli Lilly and Company (NYSE:LLY), Ellume, Ltd., EMD Biosciences, Inc., EMD Chemicals, Inc. (Acquired), EMD Millipore Corporation, Emergent BioSolutions Inc. (NYSE:EBS), Emka Technologies, Enzo Biochem, Inc. (NYSE:ENZ), Epic Sciences, Inc., Eppendorf SE, Erich NETZSCH GmbH & Co. Holding KG, Eurofins Scientific SE (ENXTPA:ERF), EUROIMMUN Medizinische Labordiagnostika AG, Everly Well, Inc., Evonetix Ltd, Exiqon A/S, F. Hoffmann-La Roche Ltd, Fabric Genomics, Inc., Fedegari Autoclavi SpA, FLIR Systems AB, Fluke Corporation, FOSS A/S, Foundation Medicine, Inc., Fuji Electric Co., Ltd. (TSE:6504), FUJIFILM Diosynth Biotechnologies U.S.A., Inc., GE Healthcare Inc., GE Healthcare Limited, GE UK Group, GenapSys, Inc. (Out of Business), Genentech, Inc., General Electric Company (NYSE:GE), Genetic Technologies Limited (ASX:GTG), Genevac Ltd., GENEWIZ, Inc., GenMark Diagnostics, Inc., Genome Diagnostics B.V., Genon Laboratories Ltd, Genovis AB (publ.) (OM:GENO), Genscript Biotech Corporation (SEHK:1548), Getinge AB (publ) (OM:GETI B), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), Graco Inc. (NYSE:GGG), Greiner AG, Greiner Group AG, Grifols USA, LLC, Guardant Health, Inc. (NasdaqGS:GH), Gyros Protein Technologies AB, Haier Group Corporation, Hamilton Company, Hardy Diagnostics, Inc., Harvard Bioscience, Inc. (NasdaqGM:HBIO), Hettich Holding GmbH & Co. oHG, Hitachi America, Ltd., Hitachi, Ltd. (TSE:6501), Hologic, Inc. (NasdaqGS:HOLX), Hongene Biotech Corporation, HORIBA, Ltd. (TSE:6856), Hospira Inc., HTG Molecular Diagnostics, Inc. (OTCPK:HTGM.Q), HyTest Ltd., IDEX Corporation (NYSE:IEX), IDEXX Laboratories Limited, IKA-Werke GmbH & Co. KG, Illumina, Inc. (NasdaqGS:ILMN), Immucor, Inc., INFICON, Inc., Ingersoll Rand Inc. (NYSE:IR), Innova Biosciences Ltd., Inostics GmbH, Inova Diagnostics, Inc., Instem plc (AIM:INS), Integrated DNA Technologies, Inc., InterGenetics Incorporated, Intertek Group plc (LSE:ITRK), inTEST Corporation (NYSEAM:INTT), Invitae Corporation (NYSE:NVTA), Invivoscribe, Inc., IonPath, Inc., iRepertoire Inc., IsoPlexis Corporation, Jasco Electronics Holdings Limited, JEOL Ltd. (TSE:6951), Johnson & Johnson (NYSE:JNJ), Johnson & Johnson Private Limited, Jordan Valley Semiconductors, Inc., K+S Aktiengesellschaft (XTRA:SDF), KBI Biopharma, Inc., Kent Scientific Corporation, Kimble Chase Life Science and Research Products LLC, KNF Neuberger, Inc., Kratos Analytical Inc., KSB, Inc., Lab Corporation, Lab Impex Systems Ltd, Laboratory Corporation of America, Inc., LabWare, Inc., LANXESS Corporation, LexaGene Holdings Inc. (OTCPK:LXXG.Q), LGC Clinical Diagnostics, Inc., LGC Limited, Lonza Cologne GmbH, Lonza Group AG (SWX:LONN), Lucira Health, Inc., Ludlum Measurements, Inc., Luminex Corporation, Magritek Inc, Magritek Limited, Malvern Panalytical Limited, Maravai LifeSciences Holdings, Inc. (NasdaqGS:MRVI), MaxCyte, Inc. (AIM:MXCT), MDS Analytical Technologies (US) Inc. (Acquired), Medical Analysis Systems, Inc., Medite Cancer Diagnostics, Inc. (OTCPK:MDIT), Medline Industries, Inc., Menarini Silicon Biosystems, Inc., Merck & Co., Inc. (NYSE:MRK), Merck KGaA (XTRA:MRK), Merck Millipore Limited, Meridian Bioscience, Inc., Meso Scale Diagnostics, LLC, MicroCal, LLC, Miltenyi Biotec B.v., Miltenyi Biotec GmbH, Miltenyi Biotec Inc., Mirion Technologies, Inc. (NYSE:MIR), Mission Bio, Inc., Mobidiag Oy, Molecular Assemblies, Inc., Monex USA, Nanalysis Scientific Corp. (TSXV:NSCI), NanoString Technologies, Inc. (NasdaqGM:NSTG), Natera, Inc. (NasdaqGS:NTRA), Nautilus Biotechnology, Inc. (NasdaqGS:NAUT), Neogen Chemicals Limited (NSEI:NEOGEN), NeoGenomics, Inc. (NasdaqCM:NEO), NETZSCH-Gerätebau GmbH, New England Biolabs Inc., New Objective Inc, Nicolet Vascular Inc., Nikon Corporation (TSE:7731), NOTOCORD Systems SAS, NOV Inc. (NYSE:NOV), Nuclera Nucleics Ltd, Nutcracker Therapeutics, Inc., O-Link Corp., Olink Holding AB (publ) (NasdaqGM:OLK), Olink Proteomics AB, Olympus Corporation (TSE:7733), Olympus Innov-X Inc., Omixon Biocomputing Ltd., One Lambda, Inc., OpGen, Inc. (NasdaqCM:OPGN), OPKO Health, Inc. (NasdaqGS:OPK), OraSure Technologies, Inc. (NasdaqGS:OSUR), Ortho-Clinical Diagnostics N.V., Owens & Minor, Inc. (NYSE:OMI), Oxford Instruments America, Inc., Oxford Instruments plc (LSE:OXIG), Oxford Nanopore Technologies plc (LSE:ONT), Pacific Biosciences of California, Inc. (NasdaqGS:PACB), Pall Corporation, PANalytical B.V., Par Pharmaceutical Companies Inc., Parallax Health Sciences, Inc., Park Systems Corp. (KOSDAQ:A140860), Parr-Physica, Patterson Companies, Inc. (NasdaqGS:PDCO), Personal Genome Diagnostics Inc., Personalis, Inc. (NasdaqGM:PSNL), Phadia AB, PharMingen, PHC Holdings Corporation (TSE:6523), Phenomenex Inc., PhenomeX Inc., PierianDx, Inc., Piramal Enterprises Limited (BSE:500302), Precipio, Inc. (NasdaqCM:PRPO), PrivaPath Diagnostics Limited, ProteinSimple, Inc., Qiagen Corporation, QIAGEN Digital Insights, Qiagen N.V. (NYSE:QGEN), Quanterix Corporation (NasdaqGM:QTRX), Quantum-Si incorporated (NasdaqGM:QSI), Quest Diagnostics Infectious Disease, Inc., QuidelOrtho Corporation (NasdaqGS:QDEL), RainDance Technologies, Inc., Rapid Micro Biosystems, Inc. (NasdaqGS:RPID), ReadCoor, Inc., Reflect Scientific, Inc. (OTCPK:RSCF), Renalytix Plc (AIM:RENX), Renishaw plc (LSE:RSW), Repligen Corporation (NasdaqGS:RGEN), Restek Corporation, Revvity, Inc. (NYSE:RVTY), Rhodia S.A., Rigaku Corporation, Roche Diagnostics Corporation, Roche Diagnostics GmbH, Roche Holding AG (SWX:ROG), Roche Molecular Systems Inc., Roche NimbleGen, Inc., Sakura Seiki Co., Ltd., Santa Cruz Biotechnology, Inc., Sanyo Corporation, SANYO North America Corporation, Sarstedt AG & Co. KG, Sartorius Aktiengesellschaft (XTRA:SRT3), Sartorius Stedim Biotech S.A. (ENXTPA:DIM), Seer, Inc. (NasdaqGS:SEER), Sequenom Inc., Seracares Limited, SGS SA (SWX:SGSN), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760), Sherlock Biosciences, Inc., Shimadzu Corporation (TSE:7701), Shire Pharma Canada ULC (Acquired), Siemens Aktiengesellschaft (XTRA:SIE), Siemens Computer Aided Diagnosis Ltd., Siemens Healthineers AG (XTRA:SHL), Siemens Healthineers, Inc., Siemens Hearing Instruments Ltd, Siemens Medical Solutions Diagnostics, Inc., Sigma-Aldrich Corporation, Sika AG (SWX:SIKA), Singular Genomics Systems, Inc. (NasdaqGS:OMIC), Smiths Detection Group Ltd., Solvay SA (ENXTBR:SOLB), SomaLogic, Inc. (NasdaqGM:SLGC), Sony Biotechnology Inc., Sony Group Corporation (TSE:6758), SOPHiA GENETICS SA (NasdaqGS:SOPH), Spectris plc (LSE:SXS), SPECTRO Analytical Instruments GmbH, SPX FLOW, Inc., Standard BioTools Inc. (NasdaqGS:LAB), Steelco SpA, STERIS plc (NYSE:STE), Streck, Inc., Sulzer Ltd (SWX:SUN), Supelco, Inc., Symrise AG (XTRA:SY1), Synthego Corporation, T2 Biosystems, Inc. (NasdaqCM:TTOO), Takara Bio Inc. (TSE:4974), Talis Biomedical Corporation (NasdaqCM:TLIS), Tarsons Products Limited (NSEI:TARSONS), Tecan Trading AG, Teledyne FLIR, LLC, Telesis Bio, Inc. (NasdaqGS:TBIO), Tempus Labs, Inc., Teva Pharmaceutical Industries Limited (NYSE:TEVA), Thermo Finnigan LLC, Tosoh Bioscience, Inc., Tosoh Corporation (TSE:4042), TriLink BioTechnologies, Inc., TSE Systems GmbH, Twist Bioscience Corporation (NasdaqGS:TWST), UCB SA (ENXTBR:UCB), Ugo Basile, Ultima Genomics, Inc., Ultivue, Inc., US Nuclear Corp. (OTCPK:UCLE), Varian, Inc. (Acquired), Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX), Vetter Pharma-Fertigung GmbH & Co. KG, Vista Outdoor Inc. (NYSE:VSTO), Vizgen, Inc., W.W. Grainger, Inc. (NYSE:GWW), WaferGen Bio-systems, Inc., Waters Corporation (NYSE:WAT), Watson-Marlow, Inc., Werfen, S.A., XCEL Power Systems Limited, Zeus Scientific, Inc.

M&A Advisors
Addleshaw Goddard LLP, Arnold & Porter Kaye Scholer LLP, Axinn, Veltrop & Harkrider LLP, Barclays Capital Inc., Barclays PLC (LSE:BARC), Bennett Jones LLP, Blake, Cassels & Graydon LLP, CMS Hasche Sigle Partnerschaft von Rechtsanwälten und Steuerberatern mbB, Cravath, Swaine & Moore LLP, Ernst & Young Transaction Advisory Services España, Five Arrows Capital Markets LLC, Foley & Lardner LLP, Foley Hoag LLP, Goldman Sachs & Co. LLC, Hale and Dorr LLP, Hammonds LLP, Hogan Lovells, J.P. Morgan Securities LLC, JPMorgan Chase & Co. (NYSE:JPM), KPMG Corporate Finance LLC, Latham & Watkins LLP, Lehman Brothers Inc., Lenz & Staehelin, Lincoln International LLC, Linklaters LLP, Linklaters LLP (USA), Merilampi Oy, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Morgan Stanley & Co. LLC, Nielsen & Nørager, Pepper Hamilton LLP, Raymond James & Associates, Inc., RBC Dominion Securities Inc., Rothschild & Co US Inc., Slaughter and May, The Beacon Group, LLC, Uría Menéndez Abogados, S.L.P., Wachtell, Lipton, Rosen & Katz LLP, Wilmer Cutler Pickering Hale and Dorr LLP


Advisors
Most Recent Auditor
PricewaterhouseCoopers LLP
M&A Advisors
Addleshaw Goddard LLP, Arnold & Porter Kaye Scholer LLP, Axinn, Veltrop & Harkrider LLP, Barclays Capital Inc., Barclays PLC (LSE:BARC), Bennett Jones LLP, Blake, Cassels & Graydon LLP, CMS Hasche Sigle Partnerschaft von Rechtsanwälten und Steuerberatern mbB, Cravath, Swaine & Moore LLP, Ernst & Young Transaction Advisory Services España, Five Arrows Capital Markets LLC, Foley & Lardner LLP, Foley Hoag LLP, Goldman Sachs & Co. LLC, Hale and Dorr LLP, Hammonds LLP, Hogan Lovells, J.P. Morgan Securities LLC, JPMorgan Chase & Co. (NYSE:JPM), KPMG Corporate Finance LLC, Latham & Watkins LLP, Lehman Brothers Inc., Lenz & Staehelin, Lincoln International LLC, Linklaters LLP, Linklaters LLP (USA), Merilampi Oy, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Morgan Stanley & Co. LLC, Nielsen & Nørager, Pepper Hamilton LLP, Raymond James & Associates, Inc., RBC Dominion Securities Inc., Rothschild & Co US Inc., Slaughter and May, The Beacon Group, LLC, Uría Menéndez Abogados, S.L.P., Wachtell, Lipton, Rosen & Katz LLP, Wilmer Cutler Pickering Hale and Dorr LLP
Private Placement Advisors
Wilmer Cutler Pickering Hale and Dorr LLP
Public Offering Advisors
Anderson Mori & Tomotsune LPC, PricewaterhouseCoopers LLP, Wilmer Cutler Pickering Hale and Dorr LLP


Most Recent Auditor
PricewaterhouseCoopers LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

06:08 AM
TMO
Thermo Fisher Scientific Inc (TMO.XNYS) - Medical Equipment - Deals and Alliances Profile
Reports
376
S&P Global Compustat

Oct 05, 2023 03:30 AM
TMO
Thermo Fisher Scientific Inc 2023_10_05
Reports
19
GlobalData

Oct 05, 2023 03:07 AM
TMO
Thermo Fisher Scientific Inc (TMO.XNYS) - Financial and Strategic SWOT Analysis Review
Reports
1,577
ValuEngine, Inc.

Oct 02, 2023 05:41 AM
TMO
ValuEngine Rating and Forecast Report for TMO
Reports
11
The Economy Matters

Oct 02, 2023 01:09 AM
TMO
The Economy Matters
Reports
8
CFRA Equity Research
Hardy, Sel
Sep 30, 2023 04:29 PM
TMO
Thermo Fisher Scientific Inc.
Reports
9
New Constructs, LLC

Sep 29, 2023 08:29 PM
TMO
TMO: Forensic Stock Earnings & Valuation
Reports
6
Ford Equity Research

Sep 28, 2023 10:00 PM
TMO
Ford Research Report - Thermo Fisher Scientific Inc.
Reports
3
MarketLine

Sep 27, 2023 06:01 AM
TMO
Thermo Fisher Scientific Inc.
Reports
76
CFRA Equity Research
Hardy, Sel
Sep 23, 2023 10:31 PM
TMO
Thermo Fisher Scientific Inc.
Reports
9


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


The Vanguard Group, Inc.

32,580,120

8.33

22,488.1

Jun-30-2023


BlackRock, Inc.

30,044,597

7.68

20,738.0

Jun-30-2023


Capital Research and Management Company

19,151,358

4.90

13,219.0

Jun-30-2023


State Street Global Advisors, Inc.

16,116,956

4.12

11,124.6

Jun-30-2023


T. Rowe Price Group, Inc.

10,997,502

2.81

7,590.9

Jun-30-2023


FMR LLC

8,485,200

2.17

5,856.8

Jun-30-2023


Geode Capital Management, LLC

6,978,869

1.78

4,817.1

Jun-30-2023


Massachusetts Financial Services Company

6,794,864

1.74

4,690.1

Jun-30-2023


Norges Bank Investment Management

5,575,563

1.43

3,848.5

Dec-31-2022


Morgan Stanley, Investment Banking and Brokerage Investments

4,913,954

1.26

3,391.8

Jun-30-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
Arthur M. Cohen & Associates LLC
3,124,051
3,113,975
TCI Fund Management Limited
3,173,182
2,339,032
RBC Global Asset Management Inc.
2,007,213
1,454,248
BNP Paribas Arbitrage Sa, Asset Management Arm
773,676
773,676
Morgan Stanley, Investment Banking and Brokerage Investments
4,913,954
484,984

Top Sellers
Sellers
Common Stock Equivalent Held
Change
FMR LLC
8,485,200
(2,135,448)
Jennison Associates LLC
116,314
(1,589,185)
BlackRock, Inc.
30,044,597
(1,378,688)
Massachusetts Financial Services Company
6,794,864
(1,337,890)
BNP Paribas Securities Corp, Asset Management Arm
0
(896,543)


S&P Global Ratings Credit Ratings
Debt Type (Rating Type)
Current Rating
Rating Date
Current CreditWatch / Outlook
Current CreditWatch / Outlook Date
Issuer Credit Rating (Local Currency LT)
A-
Jun-14-2022
Stable
6/14/2022 11:51:47 AM
Issuer Credit Rating (Local Currency ST)
A-2
Dec-09-2013
-
-
Issuer Credit Rating (Foreign Currency LT)
A-
Jun-14-2022
Stable
6/14/2022 11:51:47 AM
Issuer Credit Rating (Foreign Currency ST)
A-2
Dec-09-2013
-
-


News Headlines
Date/Time
Headline
Source
Sep-15
Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions
ENP Newswire
Sep-07
Thermo Fisher Scientific to Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 13, 2023
ENP Newswire


Company Coverage
This company is not on any Coverage List.

Products
3D Visualization Software, Accela 1000 U-HPLC, Accela 600 HPLC, Acclaim PepMap nanoLC Columns, AcroMetrix Coronavirus 2019 RNA Control, Acros Organics Ultra Pure Inorganics Products, Adaptable Furniture Systems, Adapters and Accessories, Air Flow, Ambion Products, AnalogPlus, Analytical Instrumentation Products, Ancillaries and Controls, Animal Genotypes Panels, Antibodies, Antibody Tests, Applied Biosystems HIV-1 Genotyping Kit, Applied Biosystems Axiom Genotyping Solution, ARL 9900 IntelliPower X-ray Spectrometers, Asphalt & Aggregate Testing Equipment, Asset Management Services, Atomic Absorption Systems, Auto-Samplers, Autoclaves, AutoLACT System, Automated Imaging Instruments, Automated Peripherals, Automation Systems, Autopsy Sinks & Tables, B·R·A·H·M·S PCT Direct Point of Care Assay, Backpack Style Device, Barcoded Tubes, Basic Lab Equipment & Furnishings Products, Benchtop Centrifuges, Bio-banking Services, Bio-isolation Systems, Bioinformatics Software, Biological Safety Cabinets, Biological-Specimen Management Services, Biomarker Testing Products, BioProduction Solutions, Bioreagents, Bioscience Products, Blades and Paraffin, Blood Collection Devices, Blood-Test Systems, Bottles and Containers, BOVIGAM TB Kit, BRAHMS PCT Testing Solution, Bulk Elemental Analysis Instruments and Analyzers, Bulk Flow Measurement, Business Continuity Services, Business Requirements Defining Services, Cadaver Handling & Storage Services, Calibrators, Capillary Electrophoresis Sequencing Technology, Capit-All Screw Cap Tube Capper/Decapper, Cassette and Slide Labeling Systems, CE-IVD Solid Tumor DNA Kit, Cell Culture Media, Reagents, and Plastics, Cell Therapy-Based Drugs Manufacturing Solutions, Cell-culture Products, Cellular Imaging Instruments and Software Reagents, Centrifugation Products, Chamber Slides, Checkweighing, Chemical Analysis Products, Chemical Building Blocks, Chemical Protective Suits, Chemical Ventilation Fume Hoods, Chemistry Reagents, Chromatography Columns, Chromatography Data Systems, Chromatography-Mass Spectrometry Toxicology Solution, Chromosomal Microarray, ChromQuest, CID Cameras & Imaging Technology, Clean-room and Controlled-Environment Supplies, Cleaning Services, Clinical Diagnostics/Molecular Biology Products, Clinical Laboratory Consumables and Containers, Clinical Next-Generation Sequencing Systems, Clinical Next-Generation Sequencing Technology, Clinical Research Services, Clinical Specimen Collection Products, Clinical Supply-Chain Planning and Management Services, Closures and General Chromatography Accessories, Coating Weight Gauges, Cold Chain Sample Management Solution, Collection and Transport Systems, Colorimeters, Combinatorial Chemistry Services, Combustion Analyzers, Commercial Packaging and Distribution Services, Commercial-off-the-shelf Solutions (Future), Companion Diagnostic Test, Comparator Sourcing Services, Compounders, Conical Tubes, Consulting Services, Contamination Monitoring Systems, Continuous Emission Monitoring Systems, Continuous Level Products, Controls and Calibration Verification Fluids, Conveyor Belt Scales, Conveyor Safety, Cover Glass, COVID-19 Testing Products, CQM FLEX Coal Analyzer, Cryo-Electron Microscopy Single Particle Analysis, Cryo-EM Tomography, Cryopreservation Storage Tanks, Cryopreservation System, Custom Bath, Custom Biopolymers, Custom Glass/Specialty Glass Solutions, CV2000 Automated Aliquoting Liquid Handler, Data Management Software, Database Analytical Tools, DataStick Smart, Decontamination Tents, Dedicated Supply Management Personnel Services, Dehydrated and Prepared Culture Media Products, Deoxyribonucleic Acid, Desktop Spectroscopy Software, Detectors, Development and Manufacturing Services, Diagnostic and Rapid Direct Specimen Tests, Diagnostic Kits and Reagents, Diagnostic Printed Slides, Dishes and Multidishes, Distribution of Chemicals, DNA & RNA Analysis, Document Management Systems, Dosimetry, Drug-of-Abuse Collection Kits, Drugs-of-Abuse Immunoassays, Dry Baths, Dry Blocks, Dry Powder Media, DXR Nanocarbon Analysis Packages, DXR Raman Microscope, Dye-labeled Compounds, EasyTox GC/MS Productivity Solution, EGIS System, Electrical Failure Analysis Instruments, Electrochemistry Bench Meters, Electron Microscopy Products, Electronic Laboratory Notebook, Electronic Personal Dosimeters, Electrophoresis & Power Supplies, Elemental Analysis Spectrometers, EliA Tests, EMC Test Systems, Emergency Response Trailers, Energy-dispersive Detectors, Enterprise Management Solutions, Environmental and Process Instruments, Environmental Monitoring and Sampling Equipment, Environmental Resource Centre, EpiJET 5-hmC and 5-mC Analysis Kit, Equipment Servicing, ESD & Latch-up Simulators, Extruders, Fall Protection Harnesses and Restraints, Falling-Ball Viscometers, Filterware Products (Future), Finnigan Surveyor Plus, Finnigan TSQ Quantum Ultra, Firefighting, Military, and First Responder Equipment and Supplies, Fisher Science Education, Flasks and Gas Permeable Technologies, Flat-sheet Glass Plates, Floor Models, Flow Cytometers and Imaging Platforms, Flowmeters, Fluid-handling Products and Supplies, Forensic Equipment, Freeze Dryers, Freezers, FT-IR Spectrometers and IR Microscopes, Fuel Burn-Up Measurement Systems, Furnaces, Gas & Sulfur Analyzers, Gas Chromatography Systems, Gas Density Measurement Products, Gauging Systems, Gene Editing Tools, Gene Synthesis Products, GeneArt CRISPR, GeneJET Endo-Free Plasmid Maxiprep Kit, General Lab Type III & IV Water, General Purpose Microparticles, Genetic Analyzers, Genetic Sciences Products, Genome-wide RNAi Screening Services, Gibco CTS AAV-MAX Helper-Free AAV Production System, GIBCO CTS Immune Cell SR, Gibco CTS Rotea Counterflow Centrifugation System, Gibco ExpiCHO Expression System, Gibco OncoPro Tumoroid Culture Medium Kit, Glow Discharge MS System, Haake Construction Material Cell, HAAKE Open Baths, Hand Care Products, Hand-held Survey Meters, Handheld and Automated Pipetting Systems, Handheld Personal Radiation Detectors, Handheld XRF, Heat Exchangers, Heated Bath Circulators, Heating Mantles, HeliScan microCT Analyzers, Hemostasis, Heracell VIOS, High Content Informatics Systems, High Content Screening and Analysis Products, High Purity RNA and DNA Synthesis Reagents, High Resolution Trace Mass Spectrometry Systems, High-content Screening Services, High-Purity Analytical Reagents, HLA Typing and Antibody Detection Assays, Hotplates, Human Leukocyte Antigen Typing and Testing Products, Hybrid Mass Spectrometers, Hybridization Equipment, Hyperion II Fast & Efficient Nanoprober, HyperSep SLE Solution, iCAP RQ ICP-MS Spectrometer, iCAP TQs ICP-MS for Fast and Reliable Chemical Monitoring, ICP Solution, Image Analysis Software, Immersion Coolers, ImmunoCAP Tests, Immunodiagnostic Reagent Kits, Immunosuppressant Drug Immunoassays, Inductively Coupled Plasma Mass Spectrometry Systems, Industrial Hygiene Solutions, Infrared Microscopy Products, Injection Liners, Instrument Calibration Services, Instrument Control and Data Analysis Software, Instrument Integration Solutions, Intensive Care Treatments, Inventory Management Services, Invitrogen iBright 1500 imaging system, Ion 16S Metagenomics Kit, Ion AmpliSeq HD Technology (Future), Ion AmpliSeq Immune Repertoire Assay Plus, Ion AmpliSeq SARS-CoV-2 Research Panel, Ion AmpliSeq Transcriptome Solution, Ion Beam Scanning Electron Microscopes, Ion Chromatography Systems, Ion Torrent CarrierSeq ECS Kit, Ion Torrent Genexus System, Ion Torrent Oncomine Myeloid MRD Assays, Ion Trap Systems, Isotope Ratio Mass Spectrometry Systems, iTEVA Precision Software, K-Alpha+ XPS Spectrometer, Lab Automation Software, Lab Forms, Laboratory Chemicals, Laboratory Information Management Systems, Laboratory Products, Laboratory Refrigerators, Laminar Flow Workstations, Laminate Casework Systems, LeadStream, LIMS-on-Demand, Lipofectamine MessengerMAX, Liquid Chromatography Systems, Liquid Density Measurement Products, Liquid Flow, Liquid Handling System With Robotic Tool Change, Load Indication Systems, Loss-in-Weight Feeders, LTQ Velos (Future), Lymphoid Gene Panel (Future), Magmax Wastewater Ultra Nucleic Acid Isolation Kit, Magnetic Particles, Managed Equipment Solutions, Mass Spectrometry Instruments, Mats, Maybridge Ro3 Diversity Fragment Library, Medical Beverages Products, Medical Physics Products, Metal Analyzer, Micro RNA Profiling and Custom Chemical Synthesis, Microarray Substrates, Microarray Technology, Microbeam XRF, Microbiological Incubators, Microbiology Consumables, Microcentrifuges, MicroCT Instruments, Microplate Dispensers, Microplate Fluorometers, Microplate Luminometers, Microplate Photometers, Microplate Readers, Microscope Slides, Microwave Moisture Analyzers, Microwell Plates, Moisture & Constituent Analyzers, Molecular Biology Systems & Reagents, Molecular Diagnostic Products, Molecular Spectroscopy Compliance Products, Morgue/Autopsy Room Planning, Motion Monitoring, Multi-Collector Isotope Ratio Mass Spectrometry Systems, Multi-lingual and Specialized Labeling and Distribution Services, Multi-Vendor Laboratory Instrument Services, Multimode Readers, Multiplexing Systems, MuSeek Library Preparation Kit, My Pipette Creator, NanoHPLC Systems, Natural Gas Flow Computers, Nautilus LIMS, Near-infrared Analyzers, Neoma Multicollector ICP-MS System, Neutron Flux Monitoring Systems, Neutron Generators, NextGuard X-ray Inspection Platform, Nicolet IS50 FT-IR Spectrometer, NIR Process Analyzers, NIST Traceable Size Standards, Niton XL5, Niton XL5 Analyzer, Niton XL5 Plus Handheld XRF Analyzer, Novel Fluorescent Dyes, Nuclear Interface Level Gauge, Nucleic Acid Synthesis & Labeling Products, Nucleic Acid Synthesis Reagents, Nucleic-acid Technologies, OEM and Custom Kit Assembly Services, OMNIC Specta Software, Oncomine BRCA Research Assay (Future), Oncomine Comprehensive Assay (Future), Oncomine Dx Target Test, Oncomine Myeloid Assay GX, Oncomine Precision Assay (Future), Online Analyzers, Online Bulk Material Analysis Systems, Online Sulfur Analyzers, Onsite Customer Services, Orbitrap Mass Spectrometers, Organic Chemicals, Orion AQ3070 AQUAfast Chlorine Meter, Oritavancin, Ovens, Over-Encapsulation Services, Peristaltic Pumps, Personal Protective Equipment, Pharma Analytics, Pharma Services, Pharmacokinetic-Pharmacodynamic Software, Photometric Analyzers, Pipette Tips, Pipettes, Plasma FIB-SEM DualBeams, Point Level Products, Portable and Stationary Particulate Instruments, Portable Elemental Analyzers, Portable Optical Analyzers, Pre- and Post-Analytical Automation Products, Pre-Cast Electrophoresis Gels, Precious Metals, Salts and Solutions, Prenatal Screening Services, Primary Type II Grade Water, PrioCHECK Trichinella AAd, Process Control Instruments, Process Control Software, Process Fluid Handling products, Process Mass Spectrometers, Production Cell Culture Media Solutions, Production Line Process Monitoring and Control Systems, Project Management Services, Project Planning Services, Q Exactive HF System, Q Exactive Orbitrap, Quality-Control Products, QuantStudio 5 Dx Real-Time PCR System, Radiation Measurement Products, Raman Microscopy Products, Rapid DNA platform, Rapid Molecular Products, RDO Pro DO Sensor, Reactive Intermediates, Reactor Protection Systems, Real-time Polymerase Chain Reaction Technology, Recirculating Chillers, Refrigerated Baths, Remote Monitoring Solutions, Renvo Rapid PCR Test, Repository Management and Transportation Services, Research and Safety Market Channel Products, Research Serum and Media Products, Reservoirs, Reverse Transcription - Polymerase Chain Reaction Kits, Rheometers, Risk Management Solutions, RNA Interference Reagents, RNA Oligonucleotides, RNAi in vivo Technology Dvelopment Services, Robotic Arms, Robotics, Rotors, Safeguard Systems, Safety Switches, Sample Preparation and Preservation Equipment, Sample Storage and Analysis, Sample Tubes, Sampling Systems, SARS-CoV-2 GlobalAccess Sequencing Program, Scanning Electron Microscopes, Scientific LInspector in-line Measurement and Control System, Scientific Support Services, Screening Compounds, Screening Libraries, SeCore CDx HLA Sequencing System, Self-contained Breathing Apparatus, Sensititre OptiRead Automated Fluorometric Plate Reading System, Sequencing, Detection and Purification Products, SEQUEST Software, Serology Products, Shakers, Simulation and Verification Equipment, Single-Use Bioproduction Solutions, Single-Use Bioreactor, Solid Phase Extraction Consumables, Solids Flow, Sonic Level Products, Specialized Packaging Services, Specialty Diagnostic Tests, Specialty Pharmaceutical Logistics Services, Specimax Saliva Collection Kit, Spectral Libraries, Spectral Scanning Multimode Reader, Spectroscopy Software, Stackers, Stem Cell Reprogramming Kits, Stirrers, Stream Sterilizers, Super-speed and Ultra-speed Models, Supply Chain Services, Surface Analysis Instruments, Survey Instruments, Synthetic Small Interfering RNA Vectors, Syringe Filters, Tapes, TaqCheck SARS-CoV-2 Fast PCR Assay, TaqPath COVID-19 Fast PCR Combo Kit 2.0, TaqPath COVID-19 RNase P Combo Kit 2.0, TaqPath COVID-19, Flu A, Flu B Combo Kit (Future), TaqPath COVID–19 HT Kit, TaqPath Enteric Bacterial Select Panel, TaqPath Monkeypox/Orthopox Virus DNA Kit, TaqPath Respiratory Viral Select Panel, TaqPath Zika Virus Kit (Future), Technical Services, Temperature-Controlled Repository Services, test-ignore, Therapeutic Drug Monitoring Products, Thermal Cyclers, Thermal Ionization Mass Spectrometers, Thermo Fisher Cloud, Thermo Fisher Scientifics Applied Biosystems Converge Software, Thermo Scientific 8-Channel Decapper, Thermo Scientific Athena Software, Thermo Scientific Avizo2D Software (Future), Thermo Scientific Biodiesel GC Productivity Solutions, Thermo Scientific BioPharma Finder, Thermo Scientific Cascadion SM Clinical Analyzer, Thermo Scientific Cell Growth and Discovery WorkCell, Thermo Scientific CeLLInsight CX5, Thermo Scientific Columns (Future), Thermo Scientific Compound Discoverer Software, Thermo Scientific Connects, Thermo Scientific CryoStar NX70 Cryostat, Thermo Scientific Darwin LIMS Software, Thermo Scientific Dharmacon Accell SiRNA, Thermo Scientific Dionex AutoTrace 280 PFAS Solid-Phase Extraction Instrument, Thermo Scientific Dionex ICS-5000 and ICS-4000, Thermo Scientific Dionex IonPac Columns (Future), Thermo Scientific Dosimetry Solution, Thermo Scientific DRA-EV-300 Diffuse Reflectance Accessory, Thermo Scientific DRI Hydrocodone/Hydromorphone Assay, Thermo Scientific DXR2 Raman Microscopes, Thermo Scientific DXR3 Raman Microscope, Thermo Scientific DXR3 SmartRaman Spectrometer, Thermo Scientific DXR3xi Raman Imaging Microscope, Thermo Scientific EASY-nLC 1200 System, Thermo Scientific EPA 8270D Analyzer Kit (Future), Thermo Scientific Exactive GC Orbitrap GC-MS System, Thermo Scientific Exactive LC-MS, Thermo Scientific FTIR Multi-Gas CEMS, Thermo Scientific Gemini AS, Thermo Scientific GENESYS 150 UV-V (Future), Thermo Scientific GENESYS 50 (Future), Thermo Scientific Glacios 2 Cryo-Transmission Electron Microscope, Thermo Scientific HAAKE Viscotester 3 Rotational Viscometer, Thermo Scientific HAAKE Viscotester iQ, Thermo Scientific Helios 5 Laser PFIB system, Thermo Scientific HyPerforma Single-Use Mixers, Thermo Scientific Indiko, Thermo Scientific Indiko Plus Analyzer, Thermo Scientific IPlus!, Thermo Scientific iXR Raman Spectrometer (Future), Thermo Scientific KingFisher Presto System, Thermo Scientific LabLink xL, Thermo Scientific LipidSearch Software, Thermo Scientific LTQ Orbitrap XL ETD, Thermo Scientific Lumina, Thermo Scientific MagnaRay Wavelength Dispersive X-ray spectrometer, Thermo Scientific MALDI LTQ Orbitrap, Thermo Scientific MAS, Thermo Scientific Nalgene Micron PES Filter, Thermo Scientific Nicolet IN 10 FT-IR Microscope, Thermo Scientific Nicolet iN5 Fourier Transform Infrared Microscope (Future), Thermo Scientific Nicolet RaptIR FTIR Microscope, Thermo Scientific Nicolet Summit FTIR (Future), Thermo Scientific NORAN System, Thermo Scientific Nunc High Density Cell Factory System, Thermo Scientific On-Demand Printing Systems, Thermo Scientific Orion 2395 Phosphate Analyzer, Thermo Scientific Orion 3106 COD analyzer, Thermo Scientific Orion Star T900 Series, Thermo Scientific Phenom Pharos Microscopes, Thermo Scientific Proteome Discoverer Software, Thermo Scientific Q Exactive Biopharma (Future), Thermo Scientific Q Exactive GC Hybrid Quadrupole-Orbitrap GC-MS/MS Instrument, Thermo Scientific QMS Plazomicin Immunoassay, Thermo Scientific QMS Tacrolimus Immunoassay, Thermo Scientific Sample Sizer, Thermo Scientific SampleManager LIMS – SampleManager (Future), Thermo Scientific Sensititre AST System, Thermo Scientific SMART Automation Workflow (Future), Thermo Scientific SOLA II Flare, Thermo Scientific SOLAÂµ Solid Phase Extraction Plates, Thermo Scientific STEM Maps and EDS Maps Software, Thermo Scientific Talos F200i, Thermo Scientific TMT Tags, Thermo Scientific Tox Explorer Collection, Thermo Scientific TraceFinder, Thermo Scientific TriPlus RSH AutoSampler, Thermo Scientific TruDefender FTX Analyzer, Thermo Scientific TruTools, Thermo Scientific TSQ Altis, Thermo Scientific Tundra Cryo Transmission Electron Microscope, Thermo Scientific Vanquish UHPLC, Thermo Scientific X-ray Workstation, Thermo Scientific Xcalibur Software, Thermometers, Thickness Measurement Gauges, Tilt Level Products, Tissue Cassettes and Reagents, Training Services, Transfection Reagents, Transmission Electron Microscopes, Triple Quadrupole Mass Spectrometers, TrueMark Infectious Disease Research Panels, TrueMark STI Select Panel, TruNarc, TSG Refrigerators, TSQ 8000 Evo System, Type III RO Water, Cartridges, Filters, Ultra-Low Temp Baths, Ultrapure Type I Water, Unity Lab Services, Unity Lab SmartCapture Asset Utilization Monitoring Software, UV-Visible Spectrophotometers, Vacuum Concentration Products, Vacuum Concentrators, Vacuum/Pressure Pumps, Validation Services, Vanquish Core HPLC Systems, Vehicle and Pedestrian Portals, Velos Pro, Verios G4 Extreme High-Resolution SEM, Versatile Circulator, VetMAX-Gold, Vials and Organization Systems, Viral Vector Development and Manufacturing Services, Washers, Water Analysis Instruments, Water Baths, Water Purification Systems, Web Gauging Products, Weighbelt Feeders, Western Blotting and Staining Tools, Workflow Modeling Services, X-Ray Imaging/Sources, X-Ray Microanalysis, X-Ray Spectroscopy - Diffractometry Products, XBF40


Upcoming Events
Date/Time
Type
Oct-10-2023
Conferences
Oct-10-2023
Special Calls
Oct-11-2023 7:45 AM (PST)
Company Conference Presentations
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Reporting Owner(s)
Source
Form Type
Size
Sep-21-2023
Jul-13-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
8-K/A (5.02)
309 KB
Aug-10-2023
Aug-10-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
8-K (1.01, 8.01, 9.01)
1 MB
Aug-08-2023
-
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
424B5
1011 KB
Aug-08-2023
Aug-08-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
8-K (7.01)
320 KB
Aug-07-2023
-
Thermo Fisher Scientific Inc. (NYSE:TMO)
Thermo Fisher Scientific Inc. (NYSE:TMO)
SEC
FWP
19 KB
Aug-07-2023
-
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
424B5
888 KB
Aug-04-2023
Jul-01-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
10-Q
8 MB
Jul-26-2023
Jul-26-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
8-K (2.02, 9.01)
745 KB
Jul-13-2023
Jul-13-2023
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
8-K (5.02)
311 KB
Jun-21-2023
Dec-31-2022
Thermo Fisher Scientific Inc. (NYSE:TMO)

SEC
11-K
197 KB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Pettiti, Gianluca  (Executive Vice President)
Aug-30-2023
Common Stock
(3,000)
(1,246,513)
Derivative Exercise and Sale
-
Form 4
-
Aug-30-2023
Common Stock
3,000
1,042,207
Derivative Exercise
-
Form 4
-
Aug-30-2023
Common Stock
(3,000)
(2,288,720)
Sale
-
Form 4
Casper, Marc N. (Chairman, President & CEO)
Aug-25-2023 - Aug-28-2023
Common Stock
(2,819)
(2,093,419)
Sale to Issuer
(1.46)
Form 4
-
Aug-25-2023
Common Stock
(1,886)
(1,396,844)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(572)
(426,165)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(363)
(270,409)
Sale to Issuer
-
Form 4
Boxer Esq., Michael A. (Senior VP & General Counsel)
Aug-25-2023 - Aug-28-2023
Common Stock
(310)
(230,814)
Sale to Issuer
(2.68)
Form 4
-
Aug-25-2023
Common Stock
(207)
(153,295)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(62)
(46,512)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(42)
(31,008)
Sale to Issuer
-
Form 4
Lagarde, Michel  (Executive VP & COO)
Aug-25-2023 - Aug-28-2023
Common Stock
(992)
(736,679)
Sale to Issuer
(5.31)
Form 4
-
Aug-25-2023
Common Stock
(642)
(475,644)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(219)
(162,967)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(132)
(98,069)
Sale to Issuer
-
Form 4
Britt, Lisa P. (Chief Human Resources Officer & Senior VP)
Aug-25-2023 - Aug-28-2023
Common Stock
(318)
(236,581)
Sale to Issuer
(1.84)
Form 4
-
Aug-25-2023
Common Stock
(207)
(153,295)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(68)
(50,476)
Sale to Issuer
-
Form 4
-
Aug-28-2023
Common Stock
(44)
(32,810)
Sale to Issuer
-
Form 4
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Casper, Marc N.
Chairman, President & CEO
781 622 1000
-

Nelson, Karen E.
Chief Scientific Officer & Member of Scientific Advisory Board
781 622 1000
-

Chai, Nelson Juseuk
Independent Director
781 622 1000
(415) 612-8582

Sorensen, Lars Rebien
Independent Director
781 622 1000
-

Spar, Debora L.
Independent Director
781 622 1000
-

Weisler, Dion J.
Independent Director
781 622 1000
-

Sperling, Scott M.
Independent Lead Director
781 622 1000
-
-
Chandy, Ruby R.
Independent Director
781 622 1000
-

Conrads, Thomas 
Member of Scientific Advisory Board
781 622 1000
-

Gygi, Steven P.
Member of Scientific Advisory Board
781 622 1000
-

Hahn, William C.
Member of Scientific Advisory Board
(617) 632-3155
(617) 632-2165

Harris, C. Martin
Independent Director & Member of Scientific Advisory Board
781 622 1000
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Casper, Marc N.
Chairman, President & CEO
781 622 1000
-

Williamson, Stephen 
Senior VP & CFO
781 622 1000
-

Lagarde, Michel 
Executive VP & COO
781 622 1000
-

Holmes, Joseph R.
VP & Chief Accounting Officer
781 622 1000
-

Nelson, Karen E.
Chief Scientific Officer & Member of Scientific Advisory Board
781 622 1000
-

Snyder, Ryan J.
Senior VP & Chief Information Officer
781 622 1000
-

Tejada, Rafael 
Vice President of Investor Relations
(781) 622-1356
-
rafael.tejada@thermofisher.com
Boxer, Michael A.
Senior VP & General Counsel
781 622 1000
-

Pound, Sandy B.
VP & Chief Communications Officer
781 622 1000
-

Parker, Paul G.
Senior Vice President of Strategy & Corporate Development
781 622 1000
-

Britt, Lisa P.
Chief Human Resources Officer & Senior VP
781 622 1000
-

Bauer, Konrad 
Senior Vice President of Global Business Services
781 622 1000
-

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
